Join us for the #IASLC 2026 Hot Topic Meeting on Resistance to Immunotherapy!
🗓️ June 25-27, 2026
📍 Dublin, Ireland
👉 ht26-iaslc.eventsair.site/full-program
@iaslc.bsky.social @patrickforde.bsky.social
Latest posts tagged with #IASLC on Bluesky
Join us for the #IASLC 2026 Hot Topic Meeting on Resistance to Immunotherapy!
🗓️ June 25-27, 2026
📍 Dublin, Ireland
👉 ht26-iaslc.eventsair.site/full-program
@iaslc.bsky.social @patrickforde.bsky.social
IASLC - Tarlatamab Plus Anti–PD-L1 Therapy Shows Unprecedented Overall Survival in ES-SCLC
@iaslc.bsky.social
oncodaily.com/voices/sclc-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IASLC
IASLC - 10 Most Cited Articles from the Journal of Thoracic Oncology
@iaslc.bsky.social
oncodaily.com/voices/journ...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #JTO #IASLC
IASLC - Targeted Therapies of Lung Cancer (TTLC) 2026 Is Approaching
@iaslc.bsky.social
oncodaily.com/voices/iaslc...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #TTLC #TTLC26 #TTLC2026 #IASLC
IASLC Language Guide for Oncologists: What to Say and What Not to
@iaslc.bsky.social
oncodaily.com/industry/ias...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IASLC
IASLC Introduces VIKTOR: Virtual International Knowledgebase for Thoracic Oncology Research
@iaslc.bsky.social
oncodaily.com/voices/thora...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IASLC #VIKTOR #ThoracicOncology #LungCancer
IASLC - His Presence Was Felt When He Walked into Any Room…
@iaslc.bsky.social
oncodaily.com/voices/iaslc...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IASLC
Fresh evidence on IASLC residual tumor classification: Run linked to poorer survival in operable NSCLC. Full systematic review/meta-analysis: buff.ly/EoWjoVI #NSCLC #IASLC
IASLC - Conquering Lung and Other Thoracic Cancers Worldwide in the 21st Century
@iaslc.bsky.social
oncodaily.com/voices/thora...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IASLC #LungCancer
Thoracic Circle is your space to connect, collaborate, and grow within the IASLC community. 🌐
Join the conversation today: http://bit.ly/3JnsOCb
#IASLC #ThoracicCircle #LungCancer
IASLC - New Grading System for Invasive Squamous Cell Carcinoma of the Lung
@iaslc.bsky.social
oncodaily.com/voices/iaslc...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IASLC #LungCancer
In this Japanese-language episode, Dr. Misako Nagasaka moderates a discussion with @hhorinouchi.bsky.social on highlights from #WCLC25, including FLAURA2 and HARMONi.
Listen to their insights on emerging lung cancer treatment: http://bit.ly/3Jl3Cwi
#LungCancer #Oncology #IASLC
IASLC - The Upcoming 2025 Lung Cancer Hope Summit at Lung Cancer Considered
@iaslc.bsky.social @narjustflorezmd.bsky.social
oncodaily.com/voices/lung-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IASLC #LungCancer #LungCancerConsidered
Craif、世界肺癌学会で肺がん早期発見について新たな成果を報告 #東京都 #新宿区 #マイシグナル #Craif #IASLC
Craif株式会社がIASLC WCLC 2025で肺がん早期発見に関する共同研究の成果を発表。マイシグナルの有用性が示され、国際的な注目を集めています。
Getting ready for #IASLC Asia Conference on Lung Cancer this week!
Want to know more about #JTO #JTOCRR publications or Reviewer Workshop? Happy to connect in person.
#ACLC25 @iaslc.bsky.social @jtoonline.bsky.social @elsevierhms.bsky.social #PeerReview #ScholarlyPublication
IASLC - New Lung Cancer Considered from WCLC 2025
@iaslc.bsky.social @stephenvliu.bsky.social @narjustflorezmd.bsky.social
oncodaily.com/voices/lung-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WCLC2025 #IASLC #LungCancer
IASLC - New Lung Cancer Considered Episode in Mandarin
@iaslc.bsky.social
oncodaily.com/voices/lung-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LungCancer #LungCancerConsidered #IASLC
IASLC Early Career Program - Global Education for the Next Generation of Lung Cancer Experts
@iaslc.bsky.social
oncodaily.com/voices/iaslc...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IASLC #LungCancer
What were the biggest research stories at #WCLC2025?
In this Mandarin episode of Lung Cancer Considered, Dr. Chunxia Su speaks with Dr. Yang Xia and Dr. Nan Bi about the most impactful findings from this year’s conference.
🎧 Listen here: bit.ly/3Il284D
#IASLC #LungCancer #WCLC2025 #Oncology
🛎️ Auction extended to Sept 21!
Support lung cancer research and score amazing prizes, from a Maui escape to mentoring with Dr. David Carbone.
💙 All proceeds support early-career investigators via the IASLC Foundation.
Bid before Sept 21: bit.ly/47H0swO
#IASLC #AuctionForACause #LungCancerResearch
Highlights From IASLC WCLC 2025: 35 Posts Not to Miss
@iaslc.bsky.social @stephenvliu.bsky.social @drjnaidoo.bsky.social @patrickforde.bsky.social @yvonnediaz.bsky.social
oncodaily.com/insight/high...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IASLC #WCLC #WCLC25
WCLC25: Insights and Highlights from Dr. Stephen Liu
@stephenvliu.bsky.social @iaslc.bsky.social
oncodaily.com/insight/wclc...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WCLC25 #IASLC
That's it for our LIVE coverage of 'Challenging Scenarios for Immunotherapy Treatment' at #WCLC25 🫁 Chaired by
Thanyanan Baisamut & Tom John, speakers tackled tough cases from autoimmune disease to brain metastases & ICI rechallenge
#Oncology #MedX #IASLC #LungCancer #WCLC2025
Expert insights from Satoru Miura at #WCLC25
🔹 In ICI rechallenge, irAEs recur in 18–44% of cases
🔹 #ASCO & #ESMO guidelines stress case-by-case multidisciplinary decisions
🔹 Type & severity of initial irAE aids decision
#Oncology #MedSky #IASLC #LungCancer #WCLC2025
Thomas John on immunotherapy in brain metastases at #WCLC25
🔹 CNS TME differs from extracranial sites
🔹 Most brain metastases generate immunosuppressive environments
🔹 Data shows combo immunotherapy responses are good but lack durability
#Oncology #MedSky #IASLC #LungCancer #WCLC2025
The cancer "silver tsunami" is coming! More from Roberto Ferrara on treating elderly patients with immunotherapy at #WCLC25
🔹 Performance status definition is too subjective and heterogeneous
#Oncology #MedSky #IASLC #LungCancer #WCLC2025